Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Karl-Fredrik Eriksson

Associate professor

Default user image.

Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance

Author

  • Göran Sundkvist
  • L. B. Dahlin
  • H. Nilsson
  • K. F. Eriksson
  • F. Lindgärde
  • I. Rosén
  • S. A. Lattimer
  • A. A.F. Sima
  • K. Sullivan
  • D. A. Greene

Summary, in English

Aims: Sorbitol and myo-inositol levels and morphology of sural nerve were compared with nerve function and clinical neuropathy in men with diabetic, impaired (IGT), and normal glucose tolerance. Methods: After neurography of sural nerve and determinations of sensory thresholds for vibration, warm and cold on the foot, whole nerve sural nerve biopsy was performed in 10 men with Type 1 diabetes mellitus, 10 with IGT, and 10 with normal glucose tolerance. Polyol levels were assessed by gas-liquid chromatography/mass spectrometry. Results: Sural nerve amplitudes were significantly lower and sorbitol levels significantly higher in diabetic patients (median (interquartile range)) (3.7 (3.5) μV and 643 (412) pmol/mg protein, respectively) both compared with IGT (11.3 (10.6) μV; P = 0.04 and 286 (83) pmol/mg protein; P = 0.0032, respectively) and normally glucose tolerant (10.0 (11.6); P = 0.0142 and 296 (250) pmol/mg protein; P = 0.0191, respectively) subjects. There were no differences in nerve morphology between the three groups. Nerve myo-inositol levels correlated, however, positively with cluster density (r(s) = 0.56; P = 0.0054). In diabetic and IGT subjects, sural nerve amplitudes (2.6 (3.8) vs. 12.1 (10.6) μV; P = 0.0246) and myelinated nerve fibre density (MNFD; 4076 (1091) vs. 5219 (668) nerve fibres/mm2; P = 0.0021) were significantly lower in nine subjects with clinical neuropathy than in 10 without. Conclusions: Nerve degeneration (i.e. MNFD) correlated with clinical neuropathy but not with glucose tolerance status whereas nerve myo-inositol levels positively correlated with signs of nerve regeneration (i.e. increased cluster density).

Department/s

  • Department of Clinical Sciences, Malmö
  • WCMM-Wallenberg Centre for Molecular Medicine
  • Department of Translational Medicine
  • Hand Surgery, Malmö
  • Thoracic Surgery
  • Genomics, Diabetes and Endocrinology
  • Vascular Diseases - Clinical Research
  • Cardiovascular Research - Epidemiology
  • Clinical Neurophysiology

Publishing year

2000-04

Language

English

Pages

259-268

Publication/Series

Diabetic Medicine

Volume

17

Issue

4

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Endocrinology and Diabetes

Keywords

  • Human diabetes
  • IGT
  • Peripheral nerve function
  • Sorbitol
  • Sural nerve

Status

Published

Research group

  • Hand Surgery, Malmö
  • Genomics, Diabetes and Endocrinology
  • Vascular Diseases - Clinical Research
  • Cardiovascular Research - Epidemiology

ISBN/ISSN/Other

  • ISSN: 0742-3071